We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

PTGDR rs25681: Understanding Genetic Links to Asthma

rs25681
Trait
Limited evidenceGene: PTGDR

The rs25681 variant is a genetic change located within the PTGDR gene, which provides instructions for making a receptor involved in allergic inflammation. Research has investigated this variant for its potential role in influencing asthma susceptibility by affecting how the body regulates this receptor.

What each genotype means

C/CLower attention

Typical PTGDR expression profile

This genotype represents the most common genetic configuration at this location in many populations. Research into the PTGDR gene suggests it plays a role in allergic inflammation, but the specific impact of this variant on asthma risk remains a subject of ongoing scientific debate with mixed findings across different ethnic groups.

This is the most frequent genotype observed in European and many other global populations.

C/TModerate attention

Varied PTGDR expression potential

Carrying one copy of the minor allele may influence the efficiency of PTGDR receptor transcription, which is involved in the body's response to allergic inflammation. Because studies have produced conflicting results regarding the link between this variant and asthma susceptibility, this genotype should not be considered a definitive indicator of health outcomes.

This heterozygous genotype is found in approximately 30-40% of individuals in European and admixed populations.

T/TModerate attention

Potential altered receptor regulation

This genotype involves two copies of the minor allele, which some early research suggested might alter the transcription efficiency of the DP receptor. However, because subsequent studies have failed to consistently replicate these associations across diverse populations, the clinical significance of this genotype remains limited and uncertain.

This homozygous minor genotype is the least common, appearing in roughly 5-10% of individuals in European and admixed populations.

What is the rs25681 Variant?

The rs25681 variant is a single-nucleotide polymorphism (SNP) located within the PTGDR gene on chromosome 14. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is often studied as a regulatory marker, meaning it may influence how much of the PTGDR protein is produced rather than changing the structure of the protein itself. Because it sits in a region that can affect gene expression, researchers have long hypothesized that it could alter the efficiency of the prostaglandin D2 receptor, a protein that plays a significant role in the body's inflammatory response.

The Role of the PTGDR Gene

The PTGDR gene encodes the prostaglandin D2 receptor, a member of the G protein-coupled receptor (GPCR) superfamily. These receptors act like cellular switches, sitting on the surface of cells and responding to external signals—in this case, prostaglandin D2. When this molecule binds to the receptor, it triggers a cascade of intracellular signals that can lead to inflammation. Because prostaglandin D2 is a known mediator of allergic airway inflammation, the PTGDR gene is considered a candidate for understanding the biological pathways that contribute to asthma. By modulating the receptor's activity, genetic variations in this gene may theoretically influence an individual's sensitivity to inflammatory triggers.

Research and Evidence Strength

Scientific evidence linking rs25681 and other PTGDR variants to asthma is considered limited and sometimes inconsistent. While early studies identified associations between PTGDR haplotypes and asthma in both white and black populations, suggesting a role in disease susceptibility, subsequent research has not always replicated these findings across all ethnic groups. For instance, some studies in different populations have failed to identify the same strong links, highlighting the complexity of asthma genetics. Because asthma is a multifactorial condition influenced by many genes and environmental factors, it is difficult to isolate the effect of a single SNP. Current consensus suggests that while PTGDR is a relevant biological candidate, rs25681 should not be viewed as a definitive diagnostic marker for asthma.

Population Frequency

The rs25681 variant is found at varying frequencies across different global populations. In European and admixed populations, the minor allele frequency is typically reported in the range of 0.20 to 0.30. This means that a significant portion of the population carries at least one copy of the variant allele, making it a relatively common genetic feature rather than a rare mutation.

What This Information Means for You

It is important to understand that having a specific genotype at the rs25681 location does not mean you will or will not develop asthma. Asthma is a complex disease resulting from a combination of genetic, environmental, and lifestyle factors. Genetic testing for this variant is not used in clinical practice to diagnose asthma or predict its severity. If you have concerns about respiratory health, asthma symptoms, or the management of allergic conditions, you should consult with a healthcare professional or an allergist. They can provide a proper evaluation based on your clinical history and symptoms. Never use genetic information to make decisions about medication or treatment plans without first discussing them with your clinician or pharmacist.

How common is this variant?

The minor allele frequency for rs25681 is approximately 0.20–0.30 in European and admixed populations.

Frequently asked questions

Does the rs25681 variant cause asthma?

No, the rs25681 variant does not cause asthma. It is a genetic marker that has been studied for its potential association with asthma susceptibility, but it is not a direct cause of the disease.

Can I use this SNP to predict if my child will have asthma?

No, this SNP cannot be used to predict asthma. Asthma is a complex condition influenced by many different genes and environmental factors, and this variant is not a reliable predictor.

Should I change my asthma medication based on my genotype?

No. You should never change your medication or treatment plan based on genetic information. Always consult your doctor or pharmacist before making any changes to your prescribed treatment.

Where can I find more information about PTGDR?

You can find reliable information about the PTGDR gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene functions and their roles in human health.

Sources & further reading

Educational information only, last refreshed 10/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs25681?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in PTGDR